CR Bard Picks Up Bellwether Win In Vein Filter Defect Suit

Law360, New York (June 7, 2012, 8:03 PM EDT) -- An Arizona state jury has found that a C.R. Bard Inc. vein filter is not defective and that the company did not act negligently, the medical giant said Thursday, handing it a decisive victory in the first of the suits over the device to go to trial.

Plaintiff Rosemary Everett claimed in a consolidated action that Bard's first-generation Interior Vena Cava Recovery Filter System was prone to failure. She was implanted with the device, used to prevent blood clots caused by surgery, and in less than three years it fractured and traveled to her vital organs, causing injury and necessitating another...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!